View Item 

Show simple item record

Disparities in Breast Cancer and African Ancestry: A Global Perspective
dc.contributor.authorNewman, Lisa A.en_US
dc.date.accessioned2015-04-02T15:12:15Z
dc.date.available2016-05-10T20:26:28Zen
dc.date.issued2015-03en_US
dc.identifier.citationNewman, Lisa A. (2015). "Disparities in Breast Cancer and African Ancestry: A Global Perspective." The Breast Journal 21(2): 133-139.en_US
dc.identifier.issn1075-122Xen_US
dc.identifier.issn1524-4741en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/110831
dc.description.abstractRecognition of breast cancer disparities between African‐American and White American women has generated exciting research opportunities investigating the biologic and hereditary factors that contribute to the observed outcome differences, leading to international studies of breast cancer in Africa. The study of breast cancer in women with African ancestry has opened the door to unique investigations regarding breast cancer subtypes and the genetics of this disease. International research efforts can advance our understanding of race/ethnicity‐associated breast cancer disparities within the USA; the pathogenesis of triple negative breast cancer; and hereditary susceptibility for breast cancer.en_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherAfrican‐Americanen_US
dc.subject.otherAfrican ancestryen_US
dc.subject.otherbreast cancer disparitiesen_US
dc.subject.otherbreast cancer subtypesen_US
dc.subject.othertriple negative breast canceren_US
dc.titleDisparities in Breast Cancer and African Ancestry: A Global Perspectiveen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelObstetrics and Gynecologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/110831/1/tbj12369.pdf
dc.identifier.doi10.1111/tbj.12369en_US
dc.identifier.sourceThe Breast Journalen_US
dc.identifier.citedreferenceFregene A, Newman LA. Breast cancer in sub‐Saharan Africa: how does it relate to breast cancer in African‐American women? Cancer 2005; 103: 1540 – 50.en_US
dc.identifier.citedreferenceNewman LA. Breast cancer in African‐American women. Oncologist 2005; 10: 1 – 14.en_US
dc.identifier.citedreferenceTrinkaus ME, Sayed S, Gakinya SM, Moloo Z, Hanna W, Rahim Y. Triple negative and basal‐like breast cancer in East Africa. Breast J 2011; 17: 438 – 40.en_US
dc.identifier.citedreferenceRoy I, Othieno E. Breast carcinoma in Uganda: microscopic study and receptor profile of 45 cases. Arch Pathol Lab Med 2011; 135: 194 – 9.en_US
dc.identifier.citedreferenceBird PA, Hill AG, Houssami N. Poor hormone receptor expression in East African breast cancer: evidence of a biologically different disease? Ann Surg Oncol 2008; 15: 1983 – 8.en_US
dc.identifier.citedreferenceDent R, Trudeau M, Pritchard KI. Triple‐negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 2007; 13 ( 15 Pt 1 ): 4429 – 34.en_US
dc.identifier.citedreferenceTurkoz FP, Solak M, Petekkaya I. Association between common risk factors and molecular subtypes in breast cancer patients. Breast 2013; 22: 344 – 50.en_US
dc.identifier.citedreferenceFostira F, Tsitlaidou M, Papadimitriou C. Prevalence of BRCA1 mutations among 403 women with triple‐negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study. Breast Cancer Res Treat 2012; 134: 353 – 62.en_US
dc.identifier.citedreferenceSong Q, Huang R, Li J. The diverse distribution of risk factors between breast cancer subtypes of ER, PR and HER2: a 10‐year retrospective multi‐center study in China. PLoS ONE 2013; 8: e72175.en_US
dc.identifier.citedreferenceCarey LA, Perou CM, Livasy CA. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006; 295: 2492 – 502.en_US
dc.identifier.citedreferenceMorris GJ, Naidu S, Topham AK. Differences in breast carcinoma characteristics in newly diagnosed African‐American and Caucasian patients: a single‐institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database. Cancer 2007; 110: 876 – 84.en_US
dc.identifier.citedreferenceLund MJ, Trivers KF, Porter PL. Race and triple negative threats to breast cancer survival: a population‐based study in Atlanta, GA. Breast Cancer Res Treat 2009; 113: 357 – 70.en_US
dc.identifier.citedreferenceMoran MS, Yang Q, Harris LN, Jones B, Tuck DP, Haffty BG. Long‐term outcomes and clinicopathologic differences of African‐American versus white patients treated with breast conservation therapy for early‐stage breast cancer. Cancer 2008; 113: 2565 – 74.en_US
dc.identifier.citedreferenceSharma P, Klemp JR, Kimler BF. Germline BRCA mutation evaluation in a prospective triple‐negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing. Breast Cancer Res Treat 2014; 145: 707 – 14.en_US
dc.identifier.citedreferenceGreenup R, Buchanan A, Lorizio W. Prevalence of BRCA mutations among women with triple‐negative breast cancer (TNBC) in a genetic counseling cohort. Ann Surg Oncol 2013; 20: 3254 – 8.en_US
dc.identifier.citedreferencePal T, Bonner D, Kim J. Early onset breast cancer in a registry‐based sample of African‐american women: BRCA mutation prevalence, and other personal and system‐level clinical characteristics. Breast J 2013; 19: 189 – 92.en_US
dc.identifier.citedreferenceNanda R, Schumm LP, Cummings S. Genetic testing in an ethnically diverse cohort of high‐risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA 2005; 294: 1925 – 33.en_US
dc.identifier.citedreferenceGao Q, Tomlinson G, Das S. Prevalence of BRCA1 and BRCA2 mutations among clinic‐based African American families with breast cancer. Hum Genet 2000; 107: 186 – 91.en_US
dc.identifier.citedreferenceGao Q, Neuhausen S, Cummings S, Luce M, Olopade OI. Recurrent germ‐line BRCA1 mutations in extended African American families with early‐onset breast cancer. Am J Hum Genet 1997; 60: 1233 – 6.en_US
dc.identifier.citedreferenceNewman L, Fregene A. Breast cancer in African American women and women from sub‐Saharan Africa. Cancer 2005; 103: 1540 – 50.en_US
dc.identifier.citedreferenceSurveillance, Epidemiology and End Results Program Fast Stats. Availbale at: http://seer.cancer.gov/faststats/selections (accessed September 25, 2014).en_US
dc.identifier.citedreferenceNewman LA. Breast cancer disparities: high‐risk breast cancer and African ancestry. Surg Oncol Clin N Am 2014; 23: 579 – 92.en_US
dc.identifier.citedreferenceGlobocan. Globocan 2000: Cancer Incidence, Mortality and Prevalence Worldwide. [Internet website]. 2001; Version 1.0. 2003. Available at: http://www-dep.iarc.fr/cgi-bin/exe/globosx1.exe?dtype=0select=0{00AMP00}value=11{00AMP00}sex=1 (accessed February 21, 2003).en_US
dc.identifier.citedreferenceStark A, Kleer CG, Martin I. African ancestry and higher prevalence of triple‐negative breast cancer: findings from an international study. Cancer 2010; 116: 4926 – 32.en_US
dc.identifier.citedreferenceRies L, Eisner M, Kosary C. SEER Cancer Statistics Review, 1975‐2002. 2005. Available at: http://seer.cancer.gov/csr/1975_2002/ (accessed March 9, 2006).en_US
dc.identifier.citedreferenceShamliyan T, Wang SY, Virnig BA, Tuttle TM, Kane RL. Association between patient and tumor characteristics with clinical outcomes in women with ductal carcinoma in situ. J Natl Cancer Inst Monogr 2010; 2010: 121 – 9.en_US
dc.identifier.citedreferenceLi CI, Malone KE, Saltzman BS, Daling JR. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988‐2001. Cancer 2006; 106: 2104 – 12.en_US
dc.identifier.citedreferenceInnos K, Horn‐Ross PL. Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast. Breast Cancer Res Treat 2008; 111: 531 – 40.en_US
dc.identifier.citedreferenceCollins LC, Achacoso N, Haque R. Risk factors for non‐invasive and invasive local recurrence in patients with ductal carcinoma in situ. Breast Cancer Res Treat 2013; 139: 453 – 60.en_US
dc.identifier.citedreferenceBailes AA, Kuerer HM, Lari SA, Jones LA, Brewster AM. Impact of race and ethnicity on features and outcome of ductal carcinoma in situ of the breast. Cancer 2013; 119: 150 – 7.en_US
dc.identifier.citedreferenceRoses RE, Arun BK, Lari SA. Ductal carcinoma‐in‐situ of the breast with subsequent distant metastasis and death. Ann Surg Oncol 2011; 18: 2873 – 8.en_US
dc.identifier.citedreferenceStark A, Stapp R, Raghunathan A. Disease‐free probability after the first primary ductal carcinoma in situ of the breast: a comparison between African‐American and White‐American women. Breast Cancer Res Treat 2012; 131: 561 – 70.en_US
dc.identifier.citedreferencePal SK, Childs BH, Pegram M. Triple negative breast cancer: unmet medical needs. Breast Cancer Res Treat 2011; 125: 627 – 36.en_US
dc.identifier.citedreferenceFoulkes WD, Smith IE, Reis‐Filho JS. Triple‐negative breast cancer. N Engl J Med 2010; 363: 1938 – 48.en_US
dc.identifier.citedreferenceAlluri P, Newman LA. Basal‐like and triple‐negative breast cancers: searching for positives among many negatives. Surg Oncol Clin N Am 2014; 23: 567 – 77.en_US
dc.identifier.citedreferencePerou CM. Molecular stratification of triple‐negative breast cancers. Oncologist 2011; 16 ( Suppl 1 ): 61 – 70.en_US
dc.identifier.citedreferenceChavez‐Macgregor M, Clarke CA, Lichtensztajn D, Hortobagyi GN, Giordano SH. Male breast cancer according to tumor subtype and race: a population‐based study. Cancer 2013; 119: 1611 – 7.en_US
dc.identifier.citedreferenceMillikan RC, Newman B, Tse CK. Epidemiology of basal‐like breast cancer. Breast Cancer Res Treat 2008; 109: 123 – 39.en_US
dc.identifier.citedreferenceMa H, Wang Y, Sullivan‐Halley J. Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study. Cancer Res 2010; 70: 575 – 87.en_US
dc.identifier.citedreferenceShinde SS, Forman MR, Kuerer HM. Higher parity and shorter breastfeeding duration: association with triple‐negative phenotype of breast cancer. Cancer 2010; 116: 4933 – 43.en_US
dc.identifier.citedreferencePhipps AI, Buist DS, Malone KE. Reproductive history and risk of three breast cancer subtypes defined by three biomarkers. Cancer Causes Control 2011; 22: 399 – 405.en_US
dc.identifier.citedreferenceYang XR, Chang‐Claude J, Goode EL. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 2011; 103: 250 – 63.en_US
dc.identifier.citedreferencePhipps AI, Chlebowski RT, Prentice R. Reproductive history and oral contraceptive use in relation to risk of triple‐negative breast cancer. J Natl Cancer Inst 2011; 103: 470 – 7.en_US
dc.identifier.citedreferenceNelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2009; 151: 727 – 37, W237‐742.en_US
dc.identifier.citedreferenceAmirikia KC, Mills P, Bush J, Newman LA. Higher population‐based incidence rates of triple‐negative breast cancer among young african‐american women: implications for breast cancer screening recommendations. Cancer 2011; 117: 2747 – 53.en_US
dc.identifier.citedreferenceDonenberg T, Lunn J, Curling D. A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas. Breast Cancer Res Treat 2011; 125: 591 – 6.en_US
dc.identifier.citedreferenceAkbari MR, Donenberg T, Lunn J. The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas. Clin Genet 2014; 85: 64 – 7.en_US
dc.identifier.citedreferenceAntoniou AC, Pharoah PD, McMullan G, Day NE, Ponder BA, Easton D. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population‐based study. Genet Epidemiol 2001; 21: 1 – 18.en_US
dc.identifier.citedreferenceGilliland FD. Ethnic differences in cancer incidence: a marker for inherited susceptibility? Environ Health Perspect 1997; 105 ( Suppl 4 ): 897 – 900.en_US
dc.identifier.citedreferenceKarami F, Mehdipour P. A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer. BioMed Research International 2013; 2013: 928562.en_US
dc.identifier.citedreferenceFejerman L, Haiman CA, Reich D. An admixture scan in 1,484 African American women with breast cancer. Cancer Epidemiol Biomarkers Prev 2009; 18: 3110 – 7.en_US
dc.identifier.citedreferenceRuiz‐Narvaez EA, Rosenberg L, Yao S. Fine‐mapping of the 6q25 locus identifies a novel SNP associated with breast cancer risk in African‐American women. Carcinogenesis 2013; 34: 287 – 91.en_US
dc.identifier.citedreferenceRosenberg L, Boggs DA, Bethea TN, Wise LA, Adams‐Campbell LL, Palmer JR. A prospective study of smoking and breast cancer risk among African‐American women. Cancer Causes Control 2013; 24: 2207 – 15.en_US
dc.identifier.citedreferencePalmer JR, Ruiz‐Narvaez EA, Rotimi CN. Genetic susceptibility loci for subtypes of breast cancer in an African American population. Cancer Epidemiol Biomarkers Prev 2013; 22: 127 – 34.en_US
dc.identifier.citedreferenceSchwartz T, Stark A, Pang J. Expression of aldehyde dehydrogenase 1 as a marker of mammary stem cells in benign and malignant breast lesions of Ghanaian women. Cancer 2013; 119: 488 – 94.en_US
dc.identifier.citedreferencePang J, Toy KA, Griffith KA. Invasive breast carcinomas in Ghana: high frequency of high grade, basal‐like histology and high EZH2 expression. Breast Cancer Res Treat 2012; 135: 59 – 66.en_US
dc.identifier.citedreferenceLehmann BD, Bauer JA, Chen X. Identification of human triple‐negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest 2011; 121: 2750 – 67.en_US
dc.identifier.citedreferenceChen X, Li J, Gray WH. TNBCtype: a subtyping tool for triple‐negative breast cancer. Cancer informatics 2012; 11: 147 – 56.en_US
dc.identifier.citedreferenceYu KD, Zhu R, Zhan M. Identification of prognosis‐relevant subgroups in patients with chemoresistant triple‐negative breast cancer. Clin Cancer Res 2013; 19: 2723 – 33.en_US
dc.identifier.citedreferenceMasuda H, Baggerly KA, Wang Y. Differential response to neoadjuvant chemotherapy among 7 triple‐negative breast cancer molecular subtypes. Clin Cancer Res 2013; 19: 5533 – 40.en_US
dc.identifier.citedreferenceMcGhan LJ, McCullough AE, Protheroe CA. Androgen receptor‐positive triple negative breast cancer: a unique breast cancer subtype. Ann Surg Oncol 2013; 21: 361 – 7.en_US
dc.identifier.citedreferenceThike AA, Yong‐Zheng Chong L, Cheok PY. Loss of androgen receptor expression predicts early recurrence in triple‐negative and basal‐like breast cancer. Mod Pathol 2014; 27: 352 – 60.en_US
dc.identifier.citedreferenceShah PD, Gucalp A, Traina TA. The role of the androgen receptor in triple‐negative breast cancer. Womens Health (Lond Engl) 2013; 9: 351 – 60.en_US
dc.identifier.citedreferenceMrklic I, Pogorelic Z, Capkun V, Tomic S. Expression of androgen receptors in triple negative breast carcinomas. Acta Histochem 2013; 115: 344 – 8.en_US
dc.identifier.citedreferenceMcNamara KM, Yoda T, Takagi K, Miki Y, Suzuki T, Sasano H. Androgen receptor in triple negative breast cancer. J Steroid Biochem Mol Biol 2013; 133: 66 – 76.en_US
dc.identifier.citedreferenceProctor E, Jiagge E, Kleer C. Androgen receptor expression in Ghanaian breast cancer cases: novel correlation with ALDH1 in triple‐negative tumors. Paper presented at: Society of Surgical Oncology Annual Cancer Symposium 2014; Phoenix, AZ.en_US
dc.identifier.citedreferenceSurveillance, Epidemiology, and End Results program. Cancer Fast Stats. 2014. Available at: http://seer.cancer.gov/faststats/selections.php? (accessed February 26, 2014).en_US
dc.identifier.citedreferenceJemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69 – 90.en_US
dc.identifier.citedreferenceJaeger BA, Jueckstock J, Andergassen U. Evaluation of two different analytical methods for circulating tumor cell detection in peripheral blood of patients with primary breast cancer. BioMed research international 2014; 2014: 491459.en_US
dc.identifier.citedreferenceAmirikia KC, Mills P, Bush J, Newman LA. Higher population‐based incidence rates of triple‐negative breast cancer among young African‐American women: implications for breast cancer screening recommendations. Cancer 2011; 117: 2747 – 53.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
tbj12369.pdf
Size:
534.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.